Introduction
Prevalence of diabetes is high in Singapore (8.2%). 1 Five per cent to 15% of diabetics developed foot ulcers. [2] [3] [4] In fact, the lifetime risk for a person with diabetes of developing a foot ulcer could be as high as 25%. 5 Ulcers if left untreated could lead to major amputations (below and above knee amputations). Pecoraro et al 6 showed that 84% of all lower limb amputations were due to ulceration, 61% due to sensory neuropathy and 46% due to ischaemia. Nather et al 7 found the incidence of major amputations (below and above knee) to be 27.2% in diabetics with foot complications. In Singapore, approximately 700 diabetics undergo lower limb amputations every year as a result of diabetic foot complications. 8 It is therefore very important that all diabetics should have foot screening annually to detect the "foot at risk" early. 9 Such patients could be referred to the podiatrist, orthopaedic surgeon or vascular surgeon for early intervention or monitoring. Ogrin and Sands 10 found that by identifying people at high risk of foot problems, and managing the risk factors, lower extremity amputations and foot ulcerations could be prevented.
Materials and Methods

Study Population
The study involved 2137 patients (3926 feet) who underwent foot screening at National University Hospital (NUH) from June 2006 to December 2008. Foot screening was conducted by our foot screening staff nurse (Ms K Rajeswari) in the NUH multi-disciplinary team for diabetic foot problems (DFP).
Study Protocol
A prospective study was conducted using a standardised protocol designed for foot screening. Informed consent was obtained for each participant. Ethical approval has been obtained from the NUH Ethical Board.
Firstly, a detailed history of the patient was taken. This included the marital status, education level, language of communication preferred and medical history of diabetes mellitus. Presence of complications and comorbidities of diabetes and social history were recorded. The duration of diabetes and the type of treatment received were also documented.
Examination of the foot was meticulously performed. The foot was examined for the condition of the skin and presence of callosities. A biomechanical assessment was also done including examination for bunions, lesser toe deformities and Charcot joint disease.
Neurological assessment included 10-point Semmes Weinstein (5.07) Monofi lament Testing 11 and Vibration Perception Threshold using the Neurothesiometer.
Vascular assessment performed included palpation of foot pulses, ankle brachial index and toe brachial index. Each foot assessed was classifi ed according to King's College Classifi cation. 12 Finally, education on foot care was conducted. A brochure on foot education designed by our NUH Diabetic Foot Team was also given to the patient. Figure 1 shows that of the 2137 patients (3926 feet) screened, the majority were referrals from the Division of Endocrinology (1079 patients, 50.5%), other referrals came from the Department of Orthopaedics (227 patients, 10.6%), Division of Renal Medicine (194 patients, 9.1%), Podiatry Section, Department of Rehabilitation (259 patients, 12.1%), and the Department of Medicine (378 patients, 17.7%) at NUH.
Results
Their ages ranged from 12 to 79 years, the average being 56.9 years. The majority were in the fi fth and sixth decades of life -27.9% and 30.0%, respectively (Fig. 2 ). There were 1075 males and 1062 females with a male-to-female ratio of about 1:1. The racial distribution included 1098 Chinese (51.4%), 601 Malays (28.1%), 436 Indians (20.4%) and 2 Eurasians (0.1%).
Two thousand and sixty-four patients (96.6%) had type II diabetes and only 73 (3.4%) had type I diabetes. The duration of diabetes ranged from 1 to 56 years, the average being 10.6 years. Only 34.9% of patients screened had diabetes for 1 to 5 years (Fig. 3) .
Hypertension (54.5%) was the most common comorbidity followed by nephropathy (24.0%), ischaemic heart disease (IHD) (14.3%) and cerebrovascular accident (7.2%) (Fig. 4) . (Fig. 5) .
Following foot screening, 83 patients (3.90%) were referred to specialists -75 to podiatrists, 5 to vascular surgeons and 3 to orthopaedic surgeons.
Discussion
There has been no long-term study conducted in a cohort of diabetic patients to show how foot screening directly benefi ts the patients in the long-run in reducing the incidence of major lower limb amputation. Such a study should involve a control as a group of patients who did not receive foot screening being followed-up over the same period of time. However, such a study is diffi cult to perform and would take a long period of observation to complete.
Indeed, no proper study on foot screening has been reported in literature. However, there were some reports in literature where certain aspects of foot screening, such as screening for neuropathy or screening for vasculopathy had been studied. Smeija et al 13 and Pham et al 14 screened diabetic feet for sensory neuropathy. Smeija et al 13 conducted a study on the reproducibility and accuracy of conventional clinical examination of the diabetic foot for sensory neuropathy using parameters such as pin prick sensation, proprioception testing, vibration perception testing and ankle refl ex as compared to SWMF testing. Conventional clinical examination was found to have low reproducibility and accuracy compared to monofi lament testing. SWMF was found to be a reproducible and valid test for detecting sensory neuropathy. It is recommended as the screening procedure of choice for foot screening to detect sensory neuropathy. In our protocol, SWMF is also used for screening sensory neuropathy.
In contrast, Pham et al 14 showed that the combination of clinical examination and SWMF Testing is the most sensitive method to identify patients at risk for foot ulceration compared to Vibration Perception Threshold (VPT) and foot pressure measurements.
Shin et al 15 evaluated both neuropathy and vasculopathy in their foot screening protocol. They found the SWMF and Rydel-Seiffer graduated fork to be useful tools for detecting sensory neuropathy and ABI for detecting vasculopathy. Khammash et al 16 on the other hand screened diabetic patients for lower limb ischaemia using ABI. They examined 2 cohorts of patients, 100 patients with hypertension and ischaemic heart disease with diabetes and 100 without diabetes. ABI was a useful guide for detecting lower limb ischaemia. In our study, ABI <0.8 and TBI <0.7 was taken as parameters to indicate vasculopathy.
The qualifi cation and experience of the personnel performing the foot screening is a very important consideration. Edelman et al 17 showed that there was variability in the results of foot screening depending on whether it was performed by primary care providers or performed by foot care providers. They showed that while foot care providers could accurately perform foot screening, primary care providers could not assess foot pulses and could not determine foot deformity adequately. In our protocol, foot screening was carried out by a staff nurse specially trained in foot screening (Ms K Rajeswari) who could assess all aspects of foot screening including examining for foot pulses and for foot deformity. Our results showed that with regard to neuropathy, the incidence of sensory neuropathy (33.0% based on SWMF) was high. Likewise, in our studies, VPT, another modality for sensory neuropathy using the neurothesiometer found a high percentage of patients screened to have sensory neuropathy -1552 feet (39.5%). With regard to vasculopathy, the incidence of vasculopathy (13.0% based on ABI <0.8 and 13.9% based on TBI <0.7) was likewise quite high. This may be due to the fact that many in our cohort were screened rather late after the onset of diabetes. Only 50% of the patients screened were normal (Stage 1: King's Classifi cation); 28.8% of them were found to have "feet at risk". Our fi ndings showed that only 34.9% of our patients had diabetes of less than 5 years' duration. The duration of diabetes was 6 to 10 years in 25.7% of the patients and 11 to 20 years in 23.7% of the patients. Moreover, of the 33% of feet with sensory neuropathy, 295 feet (22.6%) belonged to patients who had diabetes of 1 to 5 years in duration, whilst 1012 feet (77.4%) were from patients who had diabetes of more than 5 years duration. Of the 13.0% of feet with vasculopathy, only 13.5% (59 feet) belonged to patients who had duration of diabetes of 1 to 5 years. However, a high percentage (86.5%; 441 feet) of them belonged to those who had diabetes for more than 5 years. It was not surprising that only 50.0% of the patients were normal (Stage 1: King's Classifi cation). A higher percentage of Stage 1 cases would be seen if our patients are screened early after their onset of diabetes. Patients with diabetes must receive foot screening as soon as possible. In this way we could reduce the rate of the development of diabetic foot complications. We strongly recommend that foot screening be performed once diabetes is diagnosed.
Our fi ndings showed that 28.8% were classifi ed as Stage 2, that is, "At-Risk". Indeed, 83 patients (3.9%) of our total number receiving foot screening needed referral for specialist care to podiatrists, vascular surgeons or orthopaedic surgeons. By performing foot screening earlier in patients, the number of patients requiring referral for specialist care could be reduced.
Conclusion
Foot screening should be performed as early as possible in diabetics to detect "At-Risk" feet and prevent the development of diabetic foot complications. In this way, the risk of major amputations (below and above knee) could be further reduced. 
